Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00016237
Status:
COMPLETED
Last Update Posted:
2013-10-23
First Post:
2001-05-06
Brief Title:
Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney Bladder or Lung Cancer That Has Not Responded to Previous Treatment
Sponsor:
EMD Serono
Organization:
EMD Serono
Organization Data
Organization:
EMD Serono
Class:
INDUSTRY
Study ID:
CDR0000068612
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
EMD Serono
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Memorial Sloan Kettering Cancer Center | OTHER |
| National Cancer Institute NCI | NIH |